Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BY-NC-ND 4.0JACC: CardioOncology

Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics

  • Laura I. Yousif1
  • Wouter C. Meijers1
  • Rudolf A. de Boer1
  1. 1Department of Cardiology, Thorax Center, Erasmus MC, Cardiovascular Institute, Rotterdam, the Netherlands
Read full textPDFDOICite

Related

  1. Contemporary cardiometabolic and inflammation targeting therapies reduce residual cardiovascular risk in an endpoint harmonized meta analysis
    Musa Bin Bashir, Chen Chen, Azhgool Mohammad +2
    Scientific ReportsPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossref
  2. Systemic Immune–Inflammation Index Predicting Acute Cardiovascular Outcomes
    Yasmee Khan, Sudesh Prajapathi, Mahadev Meena +5
    Journal of clinical medicinePeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. Association of systemic immune-inflammation index with all-cause, cardiovascular and cancer-related mortality in cancer survivors : A population-based cohort study
    Lian Song, Haitao Zhu, Xiongfeng Cao +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  4. Targeting NOTCH-immune crosstalk in gliomas: from mechanisms to therapeutics.
    Safieh Ebrahimi, NoorMohammad Meshkinkhood, Ali Aliee +4
    Frontiers in oncologyPeer-reviewedCC BYFull textHuman geneticsEurope PMCCrossref
  5. Pre‐Existing and Post‐Cancer Major Cardiovascular Disease and Their Association With Mortality Outcomes Among Cancer Survivors in Australia
    Md Mijanur Rahman, Katy Bell, Grace Joshy +9
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{yousif2026cancer,
  title = {{Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics}},
  author = {Laura I. Yousif and Wouter C. Meijers and Rudolf A. de Boer},
  journal = {JACC: CardioOncology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jaccao.2026.07.011},
  url = {https://doi.org/10.1016/j.jaccao.2026.07.011},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics
AU  - Laura I. Yousif
AU  - Wouter C. Meijers
AU  - Rudolf A. de Boer
PY  - 2026
DA  - 2026/09/23
JO  - JACC: CardioOncology
DO  - 10.1016/j.jaccao.2026.07.011
UR  - https://doi.org/10.1016/j.jaccao.2026.07.011
SN  - 2666-0873
ER  -